SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-18-005618
Filing Date
2018-05-07
Accepted
2018-05-07 16:51:04
Documents
1
Period of Report
2018-05-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4050318hexter_oramedpharm.html 4  
1 OWNERSHIP DOCUMENT f4050318hexter_oramedpharm.xml 4 3879
  Complete submission text file 0001213900-18-005618.txt   5427
Mailing Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019
Business Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019 646-844-1164
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9 ALFASI JERUSALEM L3 92302
Business Address
Hexter Joshua (Reporting) CIK: 0001573235 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35813 | Film No.: 18811882